🇺🇸 FDA
Patent

US 10829427

Naphthoquinones, pro-drugs, and methods of use thereof

granted A61KA61K9/0019A61K9/5123

Quick answer

US patent 10829427 (Naphthoquinones, pro-drugs, and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K9/0019, A61K9/5123, A61K9/5146, A61P